J&J unit recalls some Duragesic pain patches in U.S.
WASHINGTON, Feb 12 (Reuters) - A unit of drug and consumer giant Johnson & Johnson (JNJ.N: Quote, Profile, Research) on Tuesday said it was recalling certain strengths of their Duragesic pain patches, which have the potential to expose patients to a dangerous gel inside.
Johnson & Johnson's Ortho-McNeil-Janssen unit is recalling all lots of its 25 microgram per hour strength patch of Duragesic, in coordination with the U.S. Food and Drug Administration.
The recalled patches may have an opening which could result in release of the gel made of the drug fentanyl inside.
Exposure to fentanyl directly can cause serious harm, including breathing problems and overdose, which can be fatal, the company said.
All the recalled patches have an expiration date on or before Dec. 2009. Some patches in Canada are also being recalled.
(Reporting by Kim Dixon)
© Thomson Reuters 2008 All rights reserved
Ads by Career Builder
Consulting Opportunity; Healthcare Expertise Required
Details: ...topic area experts for paid consultations. We are seeking Healthcare professionals with advanced knowledge and insights from diverse...
Clinical Research Solutions and Healthcare Compliance Associate
Details: ...leading academic institutions, healthcare organizations, and the law...Clinical Research Solutions/Healthcare Compliance team is a national...
CEO - Chief Executive Officer - Healthcare - Hospital
Details: ...has worked in the healthcare industry either...level, within the healthcare vertical. Utilizing...for hospitals and healthcare systems totaling...
Healthcare Sales Representative
Details: ...commercial business, healthcare, and government...salesperson to cover the healthcare and business sector...consideration in targeted healthcare building and renovation...




